Not admitted · Outside the five areas
Rules 1.1.0 · as of 14 Sep 2026
Christian Angermayer · Said 23 Feb 2024 · angermayer-0066
Quote
Outside the five areas
“My expectation is that the new autonomy we are gaining over our bodies will also make off-label-use more accepted and common and will make it a significant economic driver for the biotech pharma industry in the years ahead.”
Section on the 'Enhanced zeitgeist' after the GLP-1 discussion; claim about off-label prescribing becoming a major economic driver.
Outside the five area definitions in areas.json: not a regulatory decision, trial outcome, company or market outcome, payer or policy decision, or practice adoption about drugs, devices or treatments in psychiatry, or about payment for and access to them. The registry applies the same test when it consolidates proposed events.